导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 19.89% | 47/72 |
| 近一周 | -2.03% | 60/76 |
| 近一月 | -4.32% | 69/75 |
| 近一季 | 3.88% | 27/74 |
| 近半年 | 15.37% | 45/74 |
| 近一年 | 16.73% | 46/72 |
| 近两年 | 54.30% | 32/68 |
| 近三年 | 125.03% | 2/40 |
| 成立以来 | 241.25% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-7.10% 51/74 |
15.81% 26/74 |
10.64% 54/74 |
- - |
| 2024 | 24.94% 20/75 |
15.02% 2/67 |
3.84% 42/72 |
0.75% 53/74 |
3.84% 25/75 |
| 2023 | 63.31% 2/72 |
22.17% 1/57 |
14.30% 13/64 |
-2.75% 20/68 |
20.26% 3/72 |
| 2022 | -43.68% 43/46 |
-20.29% 40/43 |
-19.73% 42/45 |
-6.57% 21/45 |
-5.80% 40/46 |
| 2021 | -6.73% 27/43 |
-0.94% 239/312 |
7.09% 110/328 |
-10.13% 223/358 |
-2.16% 24/43 |
| 2020 | 113.30% 1/41 |
-6.15% 85/280 |
37.21% 10/295 |
31.83% 1/299 |
25.65% 12/305 |
| 2019 | 24.40% 15/35 |
11.50% 94/258 |
-2.47% 221/268 |
-3.11% 199/253 |
18.07% 7/266 |
| 2018 | -23.02% 25/31 |
- - |
- - |
- - |
-15.55% 174/241 |
| 2017 | 37.32% 6/30 |
- - |
- - |
- - |
- - |
| 2016 | -2.70% 21/31 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 广发全球精选股票(QDII)美元A VS. () |